COVID-19 Workshop on June 11: Current Best Practices for COVID-19 Management in Skilled Nursing Facilities, Part 2

Thursday, June 11, 2020, 10:30-11:00 AM EDT

Our COVID-19 Workshop Series continues on Thursdays, 10:30 – 11:00 am.

Join us for a continuation of our conversation with an infectious disease physician, a nursing facility medical director and a pharmacist as they discuss the latest COVID-19 scientific findings with a focus on the nursing home setting.

Objectives:

  • Discuss facility-specific best practices to avoid COVID-19 infection and transmission
  • Characterize strategies for testing patients and facility staff
  • Identify infection prevention strategies as facilities reopen

Materials


Have specific questions?

Let us know and we’ll address them in our upcoming webinars. Email us at: QIO-info@ipro.org.


About Our Speakers

Ghinwa Khalid Dumyati, M.D. is a professor of Infectious Disease at the University of Rochester Medical Center and serves at the Center for Community Health and Prevention in Rochester, New York. Dr. Dumyati has over 80 peer-reviewed publications and book chapters to her credit, including multiple papers relating to infectious disease among seniors and in senior care-settings.

Dallas Nelson, MD CMD FACP is an Associate Professor of Medicine at the University of the Rochester in the Division Geriatrics and aging. She is medical director of the UR Medicine Geriatrics Group, a group that serves about 3000 patients across the spectrum of long term care in the Rochester Metro Area.  She also serves as the medical director of two nursing facilities.  Dr. Nelson is the primary care physician for residents in across the long term care continuum. Dr. Nelson’s main interest are improving health care delivery to the frail older adult and educating practicing providers in geriatric medicine.

Anne Myrka, RPh, MAT has more than 25 years as a practicing, licensed pharmacist in NY and VT. She serves as IPRO’s Director of Drug Safety and has contributed to the development of multiple clinical decision support mobile application tools, improvement initiatives focused on decreasing opioid adverse drug events and medication reconciliation and anticoagulation initiatives within community coalitions.